Armistice Capital »

Iron Mountain shares owned by Armistice Capital

Quarter-by-quarter ownership of Iron Mountain (IRM) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Iron Mountain

Tip: Access up to 7 years of quarterly data

All positions including Iron Mountain held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iron Mountain by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $240k 2.4k 102.14

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Iron Mountain

Vanguard Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Cohen & Steers Capital Management
Geode Capital Management
FMR
Morgan Stanley
Principal Financial Group
Dimensional Fund Advisors
Northern Trust
Charles Schwab Investment Management
Invesco
Legal & General Group

View all funds holding Iron Mountain